Invesco Ltd. Has $4.37 Million Stake in Core Laboratories Inc. (NYSE:CLB)

Invesco Ltd. lowered its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 25.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 252,324 shares of the oil and gas company's stock after selling 84,510 shares during the quarter. Invesco Ltd. owned 0.54% of Core Laboratories worth $4,368,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Confluence Investment Management LLC raised its stake in shares of Core Laboratories by 0.4% in the fourth quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company's stock valued at $2,360,000 after purchasing an additional 599 shares in the last quarter. Isthmus Partners LLC raised its stake in shares of Core Laboratories by 5.6% in the 4th quarter. Isthmus Partners LLC now owns 11,219 shares of the oil and gas company's stock valued at $194,000 after buying an additional 599 shares in the last quarter. Tidal Investments LLC lifted its holdings in shares of Core Laboratories by 1.7% during the 3rd quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company's stock worth $813,000 after acquiring an additional 716 shares during the period. Smartleaf Asset Management LLC lifted its holdings in shares of Core Laboratories by 173.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock worth $35,000 after acquiring an additional 1,293 shares during the period. Finally, Ridgewood Investments LLC boosted its position in shares of Core Laboratories by 4.6% during the 4th quarter. Ridgewood Investments LLC now owns 32,612 shares of the oil and gas company's stock valued at $565,000 after acquiring an additional 1,428 shares in the last quarter. Institutional investors own 97.81% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CLB. StockNews.com lowered shares of Core Laboratories from a "hold" rating to a "sell" rating in a research report on Friday. Stifel Nicolaus decreased their price target on Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a research note on Tuesday, April 15th. Finally, Citigroup upgraded Core Laboratories from a "sell" rating to a "neutral" rating and increased their price objective for the stock from $15.00 to $16.00 in a research note on Wednesday, March 12th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to data from MarketBeat, Core Laboratories has a consensus rating of "Hold" and a consensus price target of $15.75.

Core Laboratories Price Performance

CLB traded down $0.55 during midday trading on Monday, hitting $11.31. The company had a trading volume of 478,231 shares, compared to its average volume of 392,352. Core Laboratories Inc. has a twelve month low of $10.14 and a twelve month high of $25.13. The company has a market capitalization of $528.20 million, a PE ratio of 17.14, a P/E/G ratio of 0.99 and a beta of 1.99. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. The firm's 50-day simple moving average is $13.87 and its 200-day simple moving average is $17.11.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The company had revenue of $123.59 million during the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. The business's revenue for the quarter was down 4.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.19 EPS. Equities research analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Monday, May 5th will be paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date is Monday, May 5th. Core Laboratories's dividend payout ratio (DPR) is 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.